bupropion hydrochloride
Generic: bupropion hydrochloride
Labeler: preferred pharmaceuticals inc.Drug Facts
Product Profile
Brand Name
bupropion hydrochloride
Generic Name
bupropion hydrochloride
Labeler
preferred pharmaceuticals inc.
Dosage Form
TABLET, EXTENDED RELEASE
Routes
Active Ingredients
bupropion hydrochloride 300 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
68788-8589
Product ID
68788-8589_9595974f-21f6-426e-8833-ae1a79a50b4a
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA211020
Listing Expiration
2026-12-31
Marketing Start
2024-02-20
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
687888589
Hyphenated Format
68788-8589
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
bupropion hydrochloride (source: ndc)
Generic Name
bupropion hydrochloride (source: ndc)
Application Number
ANDA211020 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 300 mg/1
Packaging
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8589-1)
- 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8589-3)
- 60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8589-6)
- 120 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8589-8)
- 90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8589-9)
Packages (5)
68788-8589-1
100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8589-1)
68788-8589-3
30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8589-3)
68788-8589-6
60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8589-6)
68788-8589-8
120 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8589-8)
68788-8589-9
90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8589-9)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "9595974f-21f6-426e-8833-ae1a79a50b4a", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993557"], "spl_set_id": ["c0d92aa1-638d-44dd-a7f1-26bdbb1176ef"], "manufacturer_name": ["Preferred Pharmaceuticals Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8589-1)", "package_ndc": "68788-8589-1", "marketing_start_date": "20240220"}, {"sample": false, "description": "30 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8589-3)", "package_ndc": "68788-8589-3", "marketing_start_date": "20240220"}, {"sample": false, "description": "60 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8589-6)", "package_ndc": "68788-8589-6", "marketing_start_date": "20240220"}, {"sample": false, "description": "120 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8589-8)", "package_ndc": "68788-8589-8", "marketing_start_date": "20240220"}, {"sample": false, "description": "90 TABLET, EXTENDED RELEASE in 1 BOTTLE (68788-8589-9)", "package_ndc": "68788-8589-9", "marketing_start_date": "20240220"}], "brand_name": "Bupropion Hydrochloride", "product_id": "68788-8589_9595974f-21f6-426e-8833-ae1a79a50b4a", "dosage_form": "TABLET, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "68788-8589", "generic_name": "Bupropion Hydrochloride", "labeler_name": "Preferred Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "300 mg/1"}], "application_number": "ANDA211020", "marketing_category": "ANDA", "marketing_start_date": "20240220", "listing_expiration_date": "20261231"}